Masimo (MASI) and Royal Philips (PHG) announced an expansion of their partnership to augment patient monitoring capabilities in home telehealth applications with the Masimo W1 advanced health tracking watch. The W1 will integrate with Philips’s enterprise patient monitoring ecosystem to advance the forefront of telemonitoring and telehealth. The combined innovation, which draws upon the two global medical technology leaders’ extensive expertise in monitoring, connectivity, and automation, will be highlighted later this month at Arab Health 2023. Bilal Muhsin, Chief Operating Officer of Masimo Healthcare, said, "Expanding our partnership with Philips in this way is a win-win for patients and clinicians everywhere, and is an important part of our multi-year plan to bring the best of hospital monitoring to the home while continuing to improve access to quality hospital care."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MASI:
- Stifel Predicts a Worrisome 2023 but Recommends These 2 Stocks
- Masimo price target raised to $170 from $164 at Stifel
- ITC rules Apple violated trade laws by infringing on Masimo patent
- USITC says Apple Watch infringes Masimo patent, Bloomberg reports
- Masimo announces findings from before-and-after study of Patient SafetyNet